|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized, Double- Blind, Placebo -Controlled Trial of Long -Acting Release Octreotide for Treatment of Graves' Ophthalmopathy 显示文摘 | Stan MN Garrity JA Bradley EA | 2006 | J Clin Endocrinol Metab2006，91，12： | 1 |
| 2 | Randomized, double-blind, placebo -controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy 显示文摘 | Stan MN Garrity JA Bradley EA | 2006 | J Clin Endocrinal Metab2006，91，12： | 1 |
| 3 | The evaluation and treatment of graves ophthalmopathy显示文摘 | Stan MN Garrity JA Bahn RS | 2012 | Med Clin North Am2012，96，2： | 1 |
| 4 | The Evaluation and Treatment of Graves Ophthalmopathy显示文摘 | Stan MN Garrity JA Bahn RS | 2012 | Med Clin North Am2012，96，2： | 1 |
| 5 | Risk factors for development or deterioration of Graves' ophthalmopathy显示文摘 | Stan MN Bahn RS | 2010 | Thyroid2010，20，7： | 1 |
| 6 | Randomized, double-blind, placebo-controlled trial of long-acting release oetreotide for treatment of Graves' ophthalmopathy显示文摘 | Stan MN Garrity JA Bradley EA | 2006 | J Clin Endocrinol Metab2006，91，12： | 1 |
| 7 | In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor显示文摘 | Stan AC Nemati MN Pietsch T | 1995 | J Neurosurg1995，82，6： | 1 |
| 8 | The evaluation and treatment of graves ophthalmopathy显示文摘 | Stan MN Garrity JA Bahn RS | 2012 | Med Clin North Am2012，96，2： | 1 |
| 9 | The evaluation and treatment of graves ophthalmopathy显示文摘 | Stan MN Garrity JA Bahn RS | 2012 | Med Clin North Am2012，96，2： | 1 |
| 10 | A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy显示文摘 | Kumar S Nadeem S Stan MN | | 0，，： | 1 |
| 11 | In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor 显示文摘 | Stan AC Nemati MN Pietsch T | 1995 | J Neurosurg1995，82，6： | 1 |
| 12 | Randomized controlled trial of rituximab in patients with Graves′ orbitopathy显示文摘 | Stan MN Garrity JA Carranza Leon BG | 2015 | J Clin Endocrinol Metab2015，100，2： | 1 |
| 13 | The evaluation and treatment of Graves ophthalmopathy 显示文摘 | Stan MN Garrity JA Bahn RS | 2012 | Med Clin North Am2012，96，： | 1 |
| 14 | Randomized,double-blind,placeho-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy显示文摘 | Stan MN Garrity JA Bradley EA | | 0，，： | 1 |
| 15 | The evaluation and treatment of Graves ophthalmopathy 显示文摘 | Stan MN Garrity JA Bahn RS | 2012 | Med Clin N Am2012，96，2： | 1 |
| 16 | Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy 显示文摘 | Stan MN Garrity JA Bradley EA | 2006 | J Clin Endocrinol Metab2006，91，： | 1 |
| 17 | A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy显示文摘 | Kmnar S Nadeem S Stan MN | 2011 | J Mol Endocrinol2011，46，3： | 1 |
| 18 | The evaluation and treatment of graves ophthalmopathy显示文摘 | Stan MN Garrity JA Bahn RS | 2012 | Med Clin North Am2012，96，2： | 1 |
| 19 | A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease显示文摘 | Stan MN Hess EP Bahn RS | 2012 | J Thyroid Res2012，2012，21： | 1 |
| 20 | A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves ' ophthalmopathy 显示文摘 | KUMAR S NADEEM S STAN MN COENEN M BAHN RS | 2011 | J Mol Endo- crinol2011，46，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员